First-quarter floats hold amid uncertain climate
Biotech IPOs record another strong quarter, setting the pace for a bumper year of new issues.
Tide turns as 2017 IPOs ramp up
Biotechs raised $3.9bn in IPOs across 2017, signalling that investor interest in new issues has returned.
